<DOC>
	<DOCNO>NCT02550795</DOCNO>
	<brief_summary>Previous report demonstrate dexmedetomidine could reduce incidence postoperative nausea vomiting ( PONV ) . Dexamethason also commonly use ajuvant drug prevent reduce PONV . So investigator want study effect dexmedetomidine combine dexamethasone prevent PONV .</brief_summary>
	<brief_title>Dexmedetomidine Dexmedetomidine Combined With Dexamethasone Postoperative Nausea Vomiting Breast Cancer</brief_title>
	<detailed_description>Previous report demonstrate dexmedetomidine , alpha 2 selective agonist could reduce incidence postoperative nausea vomiting ( PONV ) . Dexamethason also commonly use ajuvant drug prevent reduce PONV . So investigator want study effect dexmedetomidine combine dexamethasone prevent PONV .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ASA Physical status I II female schedule breast conserve surgery modify radical mastectomy . uncontrolled cardiovascular disease history chronic pain smoker previous history steroid administraion neoajuvant chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>